CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced it has entered into a definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings, the parent company of a licensed cultivator of cannabis. As a result of the acquisition, if completed, Tilray will obtain Natura’s 662,000 square-foot Read the full article…
CANADA: Aphria recently entered into an exclusive agreement with Toronto-based UNOapp to collaborate on the development of technology and analytics solutions for Canada’s adult-use cannabis industry. “With our innovation-focused approach, Aphria is setting the pace for the evolution of the adult-use cannabis industry in Canada,” said Jakob Ripshtein, President of Aphria. “Our industry’s long-term future will be driven by consumer-centric, innovation-led product, brand and technology solutions. We are excited for this collaboration with a fantastic technology partner in UNOapp and look forward Read the full article…
CANADA: Weekend Unlimited has announced the closing of its acquisition of the remaining 20% of California’s Canna Candys and Canna Medibles that it did not previously own. Pursuant to the original purchase and sales agreement dated September 20, 2018, Company paid US $360,000 in cash and issued 5,106,383 shares at a deemed price of $0.094 per Read the full article…
CANADA: Aphria Inc. announced that it had completed its acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products, including medical cannabis, to more than 13,000 pharmacies in Germany, as well as throughout Europe. The Company continues to strengthen its end-to-end cannabis operations and infrastructure in Germany. “As one of the most promising medical cannabis Read the full article…
CANADA: Aphria announced that its Colombian subsidiary has signed an exclusive agreement with the Federación Médica Colombiana, a national guild that oversees the ethical exercise of the medical profession in Colombia, to jointly develop an academic curriculum on the medicinal use of cannabis. “Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia” Read the full article…
CANADA: Aphria responds to the unsolicited proposal by Xanthic Biopharma d.b.a. Green Growth Brands to acquire all of the Company’s outstanding common shares in an all-stock transaction. Based on the 20-day volume weighted average price of GGB shares and the expressed exchange ratio of 1.5714 common shares of GGB for each Aphria share, the proposed bid would be Read the full article…
CANADA: Flying under the radar for the past few months, Instadose Pharma is ready to hit the market with 2 million liters of CBD oil in 2019. InstaDose Pharma has over 200,000 farmers harvesting cannabis out of the Democratic Republic of the Congo on over 100,000 hectares of land. The main production facility is GMP certified and Read the full article…
FSD Pharma Announces Strategic Investment in Huge Shops CANADA: FSD Pharma has completed a strategic investment of $1.3 million or just under 9.9% in Huge Shops, a Toronto-based cannabis retailer. Huge Shops has a strategic alliance with Chairman’s Brands, parent company of Coffee Time, a well-established operator of retail coffee shops with more than 75 locations in Read the full article…
New Partnership to Focus on Research that will Guide Responsible Innovation CANADA: AB InBev, the world’s leading brewer, and Tilray, a global pioneer in cannabis production and distribution, announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD). The partnership is limited to Canada and decisions regarding the commercialization of the beverages will Read the full article…
CANADA: Tilray Canada, a subsidiary of Tilray, a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement to collaborate with C, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products Read the full article…